PCRX - Pacira BioSciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
372,480
337,277
286,630
276,371
248,997
Cost of Revenue
95,549
86,845
87,915
110,104
71,837
Gross Profit
276,931
250,432
198,715
166,267
177,160
Operating Expenses
Research Development
61,281
55,688
57,290
45,678
28,662
Selling General and Administrative
185,257
177,265
161,494
152,613
139,043
Total Operating Expenses
248,308
232,953
218,784
198,291
167,705
Operating Income or Loss
28,623
17,479
-20,069
-32,024
9,455
Interest Expense
21,417
21,949
18,047
7,061
7,725
Total Other Income/Expenses Net
-6,869
-2,452
-8,433
-82
-288
Income Before Tax
6,231
-425
-42,471
-37,844
2,120
Income Tax Expense
-1,373
46
140
105
264
Income from Continuing Operations
7,604
-471
-42,611
-37,949
1,856
Net Income
7,604
-471
-42,611
-37,949
1,856
Net Income available to common shareholders
7,604
-471
-42,611
-37,949
1,856
Reported EPS
Basic
-
-0.01
-1.07
-1.02
0.05
Diluted
-
-0.01
-1.07
-1.02
0.04
Weighted average shares outstanding
Basic
-
40,911
39,806
37,236
36,540
Diluted
-
40,911
39,806
37,236
41,301
EBITDA
-
21,524
-24,424
-30,783
9,845